(Q30408322)

21 August 2017

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin (English)

1 reference

21 August 2017

1 reference

1 reference

Jennifer M Scalici

1

1 reference

21 August 2017

Christine Harrer

2

1 reference

21 August 2017

Anne Allen

3

1 reference

21 August 2017

Amir Jazaeri

4

1 reference

21 August 2017

Kristen A Atkins

5

1 reference

21 August 2017

Karen R McLachlan

6

1 reference

21 August 2017

Jill K Slack-Davis

7

1 reference

21 August 2017

language of work or name

English

0 references

publication date

28 December 2013

1 reference

21 August 2017

1 reference

21 August 2017

132

1 reference

21 August 2017

2

1 reference

21 August 2017

455-461

1 reference

Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Integrins as therapeutic targets.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Integrins as therapeutic targets: lessons and opportunities

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Anti-alpha4 integrin monoclonal antibody inhibits multiple myeloma growth in a murine model.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Composition of the extracellular matrix of the peritoneum

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Integrin-mediated drug resistance in multiple myeloma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Molecular mapping of functional antibody binding sites of alpha 4 integrin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3939448

Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro

26 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.031

Evidence for cell adhesion-mediated drug resistance of multiple myeloma cells in vivo

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24378876

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2013.12.031

1 reference

21 August 2017

1 reference

21 August 2017

1 reference